Us Bancorp \De\ Gilead Sciences, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,122,536 shares of GILD stock, worth $104 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,122,536

Previous 1,193,308 5.93%

Holding current value

$104 Million

Previous $81.9 Million 14.92%

% of portfolio

0.12%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$66.59 - $83.99 $4.71 Million - $5.94 Million	-70,772 Reduced 5.93%	1,122,536 $94.1 Million
Q2 2024 Aug 06, 2024	SELL	$63.15 - $72.88 $12.3 Million - $14.2 Million	-194,668 Reduced 14.03%	1,193,308 $81.9 Million
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $2.24 Million - $2.74 Million	-31,356 Reduced 2.21%	1,387,976 $102 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $2.68 Million - $3.04 Million	-36,531 Reduced 2.51%	1,419,332 $115 Million
Q3 2023 Nov 03, 2023	SELL	$73.94 - $80.67 $2.23 Million - $2.43 Million	-30,111 Reduced 2.03%	1,455,863 $109 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $5.69 Million - $6.49 Million	-74,881 Reduced 4.8%	1,485,974 $115 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $8.51 Million - $9.69 Million	-110,046 Reduced 6.59%	1,560,855 $130 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $6.82 Million - $9.8 Million	109,507 Added 7.01%	1,670,901 $143 Million
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $283,469 - $323,795	4,761 Added 0.31%	1,561,394 $96.3 Million
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $1.76 Million - $1.99 Million	-30,551 Reduced 1.92%	1,556,633 $96.2 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $3.55 Million - $4.45 Million	-61,353 Reduced 3.72%	1,587,184 $94.4 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $97,255 - $110,386	1,499 Added 0.09%	1,648,537 $120 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $3.21 Million - $3.47 Million	47,456 Added 2.97%	1,647,038 $115 Million
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $2.42 Million - $2.65 Million	38,191 Added 2.45%	1,599,582 $110 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $7.06 Million - $8.06 Million	117,679 Added 8.15%	1,561,391 $101 Million
Q4 2020 Feb 04, 2021	BUY	$56.65 - $64.55 $4.8 Million - $5.47 Million	84,815 Added 6.24%	1,443,712 $84.1 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $3.59 Million - $4.51 Million	-57,785 Reduced 4.08%	1,358,897 $85.9 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $1.44 Million - $1.67 Million	-19,837 Reduced 1.38%	1,416,682 $109 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $11.4 Million - $14.5 Million	181,229 Added 14.44%	1,436,519 $107 Million
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $763,348 - $839,658	12,388 Added 1.0%	1,255,290 $81.6 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $5.73 Million - $6.33 Million	91,724 Added 7.97%	1,242,902 $78.8 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $5.05 Million - $5.66 Million	81,548 Added 7.62%	1,151,178 $77.8 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $666,882 - $747,083	10,665 Added 1.01%	1,069,630 $69.5 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $2.1 Million - $2.74 Million	-34,735 Reduced 3.18%	1,058,965 $66.2 Million
Q3 2018 Nov 01, 2018	SELL	$71.28 - $78.92 $4.09 Million - $4.53 Million	-57,363 Reduced 4.98%	1,093,700 $84.4 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $1.3 Million - $1.51 Million	-20,009 Reduced 1.71%	1,151,063 $81.5 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $3.83 Million - $4.67 Million	52,618 Added 4.7%	1,171,072 $88.3 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $2.42 Million - $2.84 Million	33,981 Added 3.13%	1,118,454 $80.1 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $78.2 Million - $92.7 Million	1,084,473	1,084,473 $87.9 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account